Filed: 5/15/2024ACC: 0000950123-24-005234
📋 What this filing means
ABG-WTT GLOBAL LIFE SCIENCE CAPITAL PARTNERS GP LTD filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $41.52M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$41.52M
Total AUM (reported)
2.01M
Total Shares
Allocation by class
COM$40.75M98.1%
CLASS A COM$768.3K1.9%
Portfolio Concentration
Top 3$41.52M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 2.01M
Sole
Full voting authority
2.01M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
CG ONCOLOGY INC
SOLEShares915.50K
TypeSH
Market value$40.19M
96.81%
Sole
915.50K
Shared
0.00
None
0.00
RAPID MICRO BIOSYSTEMS INC
SOLEShares1.04M
TypeSH
Market value$768.3K
1.85%
Sole
1.04M
Shared
0.00
None
0.00
PULMONX CORP
SOLEShares60.20K
TypeSH
Market value$558.1K
1.34%
Sole
60.20K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 915.50K | SH | $40.19M 96.81% | 915.50K | 0.00 | 0.00 |
RAPID MICRO BIOSYSTEMS INCSOLE | CLASS A COM | 1.04M | SH | $768.3K 1.85% | 1.04M | 0.00 | 0.00 |
PULMONX CORPSOLE | COM | 60.20K | SH | $558.1K 1.34% | 60.20K | 0.00 | 0.00 |